FindMyKOL

Elisa Agostinetto

Enriched profile

Medical oncologist and breast cancer researcher · Université Libre de Bruxelles

ORCID↗NPINone on file
✓ Itemized profile
RegionNot on fileSpecialtyMedicineFocusBreast Cancer Treatment Studies+4
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Elisa Agostinetto is Medical oncologist and breast cancer researcher at Université Libre de Bruxelles. OpenAlex indexes 194 publications with 2,992 citations (h-index 28).

Data verified 8 Nov 2026

Overview

Updated 8 Nov 2026

Elisa Agostinetto is Medical oncologist and breast cancer researcher at Université Libre de Bruxelles (Faculté de Médecine). The public record shows 194 publications with 2,992 citations (h-index 28), centered on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, BRCA gene mutations in cancer.

  • Most recent indexed publication: 2026 · Journal of the National Cancer Institute
  • Top research focus: Breast Cancer Treatment Studies

Generated from the cited public record · current as of 8 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)Breast CancerGastroesophageal CancerCOVID-19Ovarian / Gynecologic CancerSarcomaNeuro-Oncology / GliomaObesity

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesBRCA gene mutations in cancerHER2/EGFR in Cancer ResearchBreast Lesions and Carcinomas

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
194publications

Publications indexed by OpenAlex, matched via ORCID. 28 in PubMed. Counts exclude supporting files.

2,992citations

Citations across these publications.

28h-index

H-index from these publications. i10-index 59.

Clinical & industry

trials, payments and federal funding
—clinical trials

Not shown. No U.S. clinical registration on file.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 8 Nov 2026

43 congress contributions (2017–2026) across AACR, ASCO, ESHRE Annual Meeting, ESMO per OpenAlex. The most recent:

Publications

Updated 8 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Congress posts on X

Post links from an X account tied to this person through reviewed identity evidence.

  1. Listed under ESMO 2026

    Collection sources

    Collected .

  2. Listed under ESMO 2026

    Collection sources

    Collected .

  3. Listed under ESMO 2026

    Collection sources

    Collected .

Explore all 18 stored posts

These links cover selected congress pages. They do not establish attendance or a complete posting history. Post availability may change.

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/ElisaAgostinett

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    European Society for Medical Oncology (ESMO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
  • Member

    American Society of Clinical Oncology (ASCO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
  • Member

    Belgian Society of Medical Oncology (BSMO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
  • Young investigator

    EORTC Breast Cancer Working Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practiceupdate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.